G1 Therapeutics Inc (NASDAQ:GTHX)
| 1.42 Delayed Data As of Sep 29 |  +0.07 / +5.19%Today’s Change | 1.17 Today|||52-Week Range 13.85 | -73.85% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Bailey Jack Jr President & Chief Executive Officer |  Sale | 1/03/2023 | 32,019 | $5.85 | $187.3K | -74.87% |
Velleca Mark A Director | Sale | 10/18/2022 | 15,000 | $11.70 | $175.5K | -87.35% |
Velleca Mark A Director | Sale | 8/08/2023 | 57,286 | $2.00 | $114.6K | -29.06% |
Bailey Jack Jr President & Chief Executive Officer | Sale | 1/04/2023 | 5,607 | $5.58 | $31.3K | -73.58% |
Velleca Mark A Director |  Buy | 8/08/2023 | 57,286 | $0.39 | $22.3K | -29.06% |
Hanson James Stillman General Counsel | Sale | 1/04/2023 | 1,639 | $5.58 | $9.1K | -73.58% |
Malik Rajesh K Chief Medical Officer | Sale | 1/04/2023 | 1,639 | $5.58 | $9.1K | -73.58% |
Murdock Terry L Chief Operating Officer | Sale | 1/04/2023 | 1,639 | $5.58 | $9.1K | -73.58% |
Moses Jennifer K Chief Financial Officer | Sale | 1/04/2023 | 1,639 | $5.58 | $9.1K | -73.58% |
Bailey Jack Jr President & Chief Executive Officer | Sale | 7/05/2023 | 2,719 | $2.45 | $6.7K | -42.17% |
Page of 5